COVID-19 and rheumatology: is shielding really necessary?-Reference-Cited by-同舟云学术

COVID-19 and rheumatology: is shielding really necessary?

Published:2020-06-02 Issue:6 Volume:81 Page:1-3
ISSN:1750-8460
Container-title:British Journal of Hospital Medicine
language:en
Short-container-title:Br J Hosp Med

Author:

Amani Lisa¹,Warraich Rabia¹,Patel Nishil²,Tahir Hasan³⁴

Affiliation:

1. Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK

2. Department of Clinical Haematology, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK

3. Department of Rheumatology and General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK

4. Division of Medicine, University College London, London, UK

Abstract

Rheumatology patients who are taking immunosuppressants are considered to be at ‘high risk’ from COVID-19, hence have been self-isolating or shielding. However, they may be protected from the features of hyperinflammation driven by a ‘cytokine storm’, so may have better clinical outcomes if infected. This editorial discusses whether it may not be necessary to advise these patients to shield.

Publisher

Mark Allen Group

Subject

General Medicine

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2020.0284

Reference7 articles.

1. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. COVID-19: consider cytokine storm syndromes and immunosuppression

4. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

5. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amazon Echo Show as a Multimodal Human-to-Human Care Support Tool within Self-Isolating Older UK Households;Proceedings of the ACM on Human-Computer Interaction;2022-11-07

2. Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality;Rheumatology;2022-05-14

3. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study;JMIR Public Health and Surveillance;2021-09-20

4. SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology;Frontiers in Immunology;2021-06-11

5. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study (Preprint);2021-05-15